Latest News for: mmj

Edit

Federal Judge to Decide Whether Medicare Can Distribute Hemp-Marijuana Cannabinoids Without FDA Approval

ACCESSWIRE 26 Apr 2026
MMJ International Holdings, an FDA IND-stage pharmaceutical cannabinoid developer, is a plaintiff in landmark litigation before the U.S ... $10M+ invested by MMJ in FDA-compliant cannabinoid development ... About MMJ International Holdings.
Edit

MMJ International Holdings Joins Federal Lawsuit on 4/20 to Stop CMS From Introducing Unvalidated Cannabinoid ...

Rutland Herald 25 Apr 2026
"MMJ International Holdings Joins Smart Approaches to Marijuana et al, Federal Challenge to CMS Hemp Program on 4/20. "Botanical Therapies Must Meet FDA Standards -Not Political Timelines" said Duane Boise MMJ International Holdings CEO ....
Edit

Group Seeking Court Order to Halt CMS Medicare THC Hemp Marijuana Program

ACCESSWIRE 25 Apr 2026
The filing, submitted by Burke Law Group on behalf of multiple plaintiffs including MMJ International Holdings, directly challenges CMS's authority and asserts that the program causes ongoing competitive harm to FDA pathway drug developers.
Edit

Trump Marijuana Schedule III Is Not Deregulation - It Activates U.S. Treaty Obligations and Federal ...

ACCESSWIRE 24 Apr 2026
For pharmaceutical cannabinoid developer MMJ International Holdings, these developments confirm what the company has maintained for years. ... MMJ International Holdings was ... MMJ International Holdings Built Its Platform Around Treaty Compliance.
Edit

Trump Pushes Cannabis Rescheduling as Hemp CMS Issues Play Out in Federal Court

ACCESSWIRE 22 Apr 2026
MMJ International Holdings followed the FDA botanical drug pathway from the beginning, and Federal healthcare programs should not introduce cannabinoid products into the Medicare population until those same standards are satisfied.".
Edit

4/20 and the Future of Cannabis Medicine: Why Botanical Therapies Must Meet Real Scientific Standards

ACCESSWIRE 20 Apr 2026
A 4/20 Message From MMJ Leadership. "April 20 has always been a day about access," said Duane Boise, President & CEO of MMJ International Holdings ... MMJ International Holdings Took the Hard Path-On Purpose ... MMJ International Holdings believes they must.
Edit

MMJ International Holdings Seeks Federal Preliminary Injunction May 1 to Halt CMS Hemp-CBD Medicare Pilot

Corsicana Daily Sun 17 Apr 2026
"MMJ followed the federal FDA pathway because patients deserve ...
Edit

Why the CMS Hemp CBD Program Lawsuit Poses Real Legal Risk

ACCESSWIRE 14 Apr 2026
CMS has created a federal cannabinoid access pathway inside Medicare infrastructure without requiring FDA drug approval, while simultaneously holding pharmaceutical developers like MMJ to the highest clinical standards in the world ... Yet MMJ..
Edit

MMJ International Holdings Seeks Injunction to Halt CMS CBD Program

The Galveston Daily News 13 Apr 2026
Federal Lawsuit Challenges CMS Hemp-CBD Medicare Pilot as Unlawful Policy Shortcut - MMJ International Holdings Says Case Exposes Regulatory Overreach That Undermines FDA Drug Approval Standards ....
Edit

Seniors Being Used As CBD Guinea Pigs In CMS Program?

ACCESSWIRE 12 Apr 2026
MMJ International Holdings and its subsidiaries MMJ BioPharma Labs and MMJ BioPharma Cultivation have moved to participate in the litigation to ensure that ... Through its subsidiaries MMJ BioPharma ...
Edit

MMJ International Holdings Enters Legal Fight Over CMS Hemp Pilot

News-Press Now 10 Apr 2026
" A federal pilot built on the 0.3% ...
Edit

Washington's Hemp Shell Game: How Medicare Dollars Are Funding Non-Approved Products While FDA-Compliant Medicines Wait

ACCESSWIRE 09 Apr 2026
For nearly a decade, pharmaceutical innovators like MMJ International Holdings have operated under a consistent federal mandate ... The Clinical Path (MMJ) ... MMJ International Holdings stands with those who demand a "science-first" approach.
Edit

Marijuana Rescheduling Countdown: Why the "Order of Operations" and Todd Blanche's Appointment Define the Path ...

ACCESSWIRE 08 Apr 2026
The MMJ Stance ... About MMJ International Holdings MMJ International Holdings is a leading biopharmaceutical company dedicated to the development of plant-derived, FDA-approved cannabinoid medicines ... MMJ International Holdings.
Edit

Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is ...

Corsicana Daily Sun 07 Apr 2026
Duane Boise CEO stated, "As cannabinoid policy shifts from retail ...
Edit

Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector

News-Press Now 06 Apr 2026
... botanical drug pipelines-like MMJ International .

Article Search

tools
×
×
×
×